Picture of Stablecoin Development logo

SDEV Stablecoin Development News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapValue Trap

Brief: Novabay Pharmaceuticals Reports Third Quarter 2021 Financial Results

Nov 11 (Reuters) - NovaBay Pharmaceuticals Inc  NBY.A :
    * NOVABAY PHARMACEUTICALS REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE $0.05

Source text for Eikon:  ID:nBwcgSD36a 
Further company coverage:  NBY.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Stablecoin Development

See all news